Incyclix Bio: Incyclix Bio Raises $30M in Series B Financing

Incyclix Bio, a Reserch Thriangle Park, NC-based cell cycle control company, raised $30M in Series B funding. The round was led by Boxer Capital with participation from RA Capital Management and Eshelman Ventures. Sid Subramony, Ph.D., Vice President of Boxer Capital, will join Incyclix Bio's board of directors. Nathaniel Brooks Horwitz, Principal of RA Capital [...] The post Incyclix Bio Raises $30M in Series B Financing appeared first on FinSMEs.